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To establish the most sensitive and efficient strategy
of clonality diagnostics via immunoglobulin and T-
cell receptor gene rearrangement studies in suspected
lymphoproliferative disorders, we evaluated 300 sam-
ples (from 218 patients) submitted consecutively for
routine diagnostics. All samples were studied using
the BIOMED-2 multiplex polymerase chain reaction
(PCR) protocol. In 176 samples, Southern blot (SB)
data were also available, and the two types of molec-
ular results were compared. Results of PCR and SB
analysis of both T-cell receptor and immunoglobulin
loci were concordant in 85% of samples. For discor-
dant results, PCR results were more consistent with
the final diagnosis in 73% of samples. No false-nega-
tive results were obtained by PCR analysis. In con-
trast, SB analysis failed to detect clonality in a rela-
tively high number of samples, mainly in cases of low
tumor burden. We conclude that the novel BIOMED-2
multiplex PCR strategy is of great value in diagnosing
patients with suspected B- and T-cell proliferations.
Because of its higher speed, efficiency, and sensitiv-
ity, it can reliably replace SB analysis in clonality
diagnostics in a routine laboratory setting. Just as
with SB results, PCR results should always be inter-
preted in the context of clinical, immunophenotypi-
cal, and histopathological data. (J Mol Diagn 2005,
7:495–503)
In most patients with suspected lymphoproliferative dis-
orders, discrimination between reactive and malignant
cell populations can be assessed by histomorphology or
cytomorphology supplemented with immunohistochemis-
try or flow cytometric immunophenotyping. However, in 5
to 10% of patients, diagnosis is more complicated and
less straightforward. In such cases, molecular gene re-
arrangement studies have proved useful as an additional
diagnostic tool. Molecular clonality analysis is based on
the fact that, in principle, all cells of a malignancy have a
common clonal origin and show clonally (identically) re-
arranged immunoglobulin (Ig) or T-cell receptor (TCR)
genes. The diagnosis of malignant B- and T-cell prolifer-
ations is therefore supported by the finding of Ig/TCR
gene clonality, whereas reactive lymphoproliferations
show polyclonally rearranged Ig/TCR genes.1
Gene rearrangement analysis can be performed by
Southern blot (SB)- and polymerase chain reaction
(PCR)-based techniques. Despite the high reliability of
SB analysis, it is increasingly replaced by PCR tech-
niques because of the greater efficiency and sensitivity of
PCR. Moreover, PCR is relatively easy, less labor inten-
sive, and requires much less high-molecular-weight
DNA. Also, SB analysis cannot be performed on paraffin-
embedded tissue because the isolated DNA is often
degraded. Therefore, there is a strong need to replace
SB analysis with reliable PCR techniques. However, PCR
studies have often suffered from false-negative results
due to improper annealing of primers and/or the pres-
ence of somatic hypermutation.2
Both SB and PCR analyses of the immunoglobulin
heavy chain (IGH) locus have been demonstrated to be
very useful and reliable techniques in clonality assess-
ment of suspected B-cell malignancies. However, the
most useful gene target for identifying T-cell clonality is
less well established. In virtually all PCR studies, only the
T-cell receptor- (TCRG) locus was analyzed at the DNA
level because of the relative structural simplicity of the
gene.3,4 PCR analysis of the T-cell receptor- (TCRB)
locus as a diagnostic test has been performed mostly on
cDNA using V and C primers. Recently, the BIOMED-
2-based TCRB gene rearrangement analysis was evalu-
ated in a large series of well-defined samples from im-
mature and mature T-cell malignancies and was
demonstrated to be a very reliable assay.5 However,
these novel BIOMED-2 multiplex PCR methods for de-
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tecting B- and T-cell clonality have yet to be validated in
routine diagnostic laboratory settings.
The vast majority of lymphoid malignancies encoun-
tered in the West belong to the B-cell lineage (90 to 95%).
Even though B-cell clonality can be assessed by flow
cytometric immunophenotyping, Ig gene rearrangement
analysis is the only reliable assay for paraffin-embedded
and frozen tissue biopsies. Consequently, in many rou-
tine diagnostic laboratories, TCR gene rearrangement
analysis is applied to a smaller number of cases per year
than Ig analysis, resulting in a lower level of experience.
Because our institute is a reference center for clonality
analysis in suspected T-cell proliferations, we routinely
obtain many T-cell proliferation samples each year.
In our study, we performed a comparative prospective
study of SB-PCR Ig/TCR gene rearrangements on a se-
ries of 300 specimens consecutively obtained for routine
diagnostics. In general, SB analysis was performed with
optimized DNA probes for the IGH locus and the TCRB
locus.6,7 To determine B- or T-cell clonality by PCR anal-
ysis, we analyzed the IGH, TCRB, and TCRG genes. To
this end, we used the well-defined and fully standardized
set of oligonucleotide primers and PCR protocols of the
BIOMED-2 Concerted Action BMH4-CT98-3936.8,9 Re-
sulting PCR products were analyzed by both heterodu-
plex (HD) and GeneScan (GS) analysis to evaluate the
diagnostic value of these methods.
Our results show that the BIOMED-2 PCR-based TCR
gene rearrangement analysis is more sensitive in detect-
ing T-cell clonality than SB analysis. In instances of dis-
cordance, PCR results demonstrated agreement with his-
topathological diagnosis more often than SB analysis.
The higher sensitivity of PCR analysis over SB analysis
also holds for IGH gene rearrangements. Based on these
results, we discuss the most sensitive and efficient strat-
egy of molecular clonality analysis.
Materials and Methods
Patients
From June 2001 until February 2004, 300 DNA samples
from fresh or frozen tissue samples (peripheral blood
[PB], n  110; lymph node [LN], n  68; bone marrow
[BM], n  28; skin, n  59; bowel, n  7; liver, n  3;
spleen, n  1; thyroid, n  1; vitreous fluid, n  15;
cerebrospinal fluid (CSF), n  3; pleural fluid, n  2;
adenoid, n  1; brain, n  1; and maxillary sinus tissue,
n  1) were prospectively collected from a total of 218
patients with suspected malignant lymphoproliferation.
Most patients were seen and followed by physicians at
the Erasmus MC, University Medical Center (Rotterdam),
especially at the Departments of Hematology and Der-
matology. Diagnoses were based on a combination of
clinical, histological, immunophenotypical, and cytomor-
phological data. Patients diagnosed with a malignancy
were classified according to the World Health Organiza-
tion classification of lymphoid neoplasms.10
DNA Isolation
High-molecular-weight DNA from fresh or frozen tissue
samples was obtained by one of two methods. In the first,
DNA was extracted using a phenol-chloroform extraction-
based protocol, followed by ethanol precipitation and
re-solubilization in Tris-EDTA buffer.1 Alternatively, DNA
was isolated using the GenElute Mammalian Genomic
DNA miniprep kit (Sigma-Aldrich, St. Louis, MO) accord-
ing to the manufacturer’s protocol.
Southern Blot Analysis
DNA (20 g) was digested with appropriate restriction
enzymes, size fractionated in 0.7% agarose gels, and
transferred to nylon filters as described elsewhere.1 The
Ig and TCR gene rearrangements were detected by use
of 32P random oligonucleotide-labeled probes. The
IGHJ6 probe (DakoCytomation, Inc., Carpinteria, CA)
was used for analyzing IGH genes in combination with
BglII or BamHI/HindIII digests,6 whereas the TCRBJ1 and
TCRBJ2 probes (DakoCytomation) were used for analyz-
ing TCRB genes in combination with EcoRI, BglII, and
BamHI/HindIII digests.7 In a selected number of cases
(n  11), the TCRG and TCR- (TCRD) gene rearrange-
ments were studied as well. For analysis of TCRG gene
rearrangements, the TCRGJ13 probe was used in com-
bination with EcoRI and Pstl digests,11 whereas the
TCRDJ1 probe was used in combination with EcoRI di-
gests for analysis of TCRD gene rearrangements.12 In the
case of clinical suspicion of natural killer cell lymphoma
and Epstein-Barr virus (EBV) infection, the presence of
(clonal) EBV genome was assessed using the XhoI probe
in BamHI/HindIII-digested DNA.13
PCR Amplification
All amplification reactions were performed in an auto-
mated thermocycler (model ABI 9600/9700; Applied Bio-
system, Foster City, CA) according to the BIOMED-2
multiplex PCR protocol.8 Each 50-l PCR reaction in-
cluded 100 ng of DNA, 10 pmol of 5 and 3 oligonucle-
otide primers, 0.2 mmol/L dNTP, 5 l of 10 buffer II
(TCRB and TCRG), or 5 l of 10 Gold buffer (IGH and
IGK), and 1 to 2 U of Ampli-Taq Gold polymerase (Ap-
plied Biosystems). The concentration of MgCl2 ranged
from 1.5 mmol/L (TCRB tube C, TCRG, IGH, and IGK) to 3
mmol/L (TCRB tubes A and B). The cycling parameters
were as follows: pre-activation for 7 minutes at 95°C,
followed by 35 cycles of 30 seconds denaturation at
95°C,30 seconds annealing at 60°C, and30 seconds
extension at 72°C. After the last cycle, a final extension
step of at least 10 minutes at 72°C was performed.
For amplification of IGH rearrangements, we used six
framework FR1-VH primers, seven FR2-VH primers, seven
FR3-VH primers, and one carboxyfluorescein-labeled JH
consensus primer in three multiplex combinations (IGH
multiplex tubes A, B, and C). DNA from the precursor
B-cell line NALM-6 was used as a positive control. In the
case of inconclusive IGH gene results, the samples were
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further analyzed using multiplex PCR reactions for the
Ig- (IGK) genes. For amplification of the IGK locus, we
used seven V primers, two FAM-labeled J primers, one
intron RSS primer, and one FAM-labeled Kde primer in
two combinations (IGK multiplex tubes A and B). For
amplification of TCRB rearrangements, V family and
FAM-labeled J primers were used in two different com-
binations (TCRB multiplex tubes A and B) and in one
combination containing D and J primers (TCRB multi-
plex tube C). DNA obtained from the following immature
T-cell lines was used as a positive control: RPMI-8402
(tube A), CML-T1 (tube B), and Jurkat (tube C). For
amplification of TCRG genes, we used V and FAM-
labeled J primers in two multiplex combinations (tubes
A and B).8 Positive controls consisted of DNA from im-
mature T-cell lines MOLT 3, RPMI-8402 (tube A), and
Jurkat (tube B). In a few cases, TCRD rearrangements
were analyzed using a single multiplex tube containing
V, J, and D primers. All BIOMED-2 multiplex PCR
tubes were obtained from InVivoScribe Technologies
(Carlsbad, CA; www.invivoscribe.com). All cell lines are
available at the Deutsche Sammlung von Mikroorganis-
men und Zellkulturen GmbH (Braunschweig, Germany).
Features of these cell lines have been summarized in
detail elsewhere.14
After Ig/TCR amplification, 10 l of PCR products was
loaded on 1% agarose gels to check whether PCR prod-
ucts had been formed. Subsequently, PCR products
were further analyzed by heteroduplex and GeneScan
analysis (see below) to assess whether the obtained PCR
products were derived from monoclonal or polyclonal cell
populations.
Heteroduplex and GeneScan Analyses
The PCR products for HD analysis were denatured at
94°C for 5 minutes and subsequently renatured at 4°C for
60 minutes to induce duplex formation.15 Afterwards, the
duplexes were immediately loaded on 6% nondenaturing
polyacrylamide gels in 0.5 Tris-boric acid-EDTA buffer,
run at ambient temperature, and visualized by ethidium
bromide staining. A 100-bp DNA ladder (Promega Cor-
poration, Madison, WI) was used as size marker.
GeneScan analysis was performed using an auto-
mated ABI PRISM 377 fluorescent sequencer (Applied
Biosystems) for the majority of PCR products, whereas
the remaining samples were analyzed using an ABI 3100
Genetic Analyzer (Applied Biosystems). When using the
first detection method (ABI 377), 2 l of 10 diluted PCR
products were mixed with 2.0 l of formamide, 0.5 l of
6-carboxytetramethylrhodamine-labeled internal stan-
dard (Genescan 500-TAMRA; Applied Biosystems), and
0.5 l of loading buffer (blue dextran). After denaturation
at 95°C for 2 minutes and cooling, 3 l of the mixture was
size-separated on a high-resolution polyacrylamide gel
and analyzed. The size and profile of the PCR products
was determined using GeneScan Analysis software v. 2.1
(Applied Biosystems).16,17
For the second method (ABI 3100), 1 l of a 5 dilution
of PCR products was added to 10 l of a MilliQ:rhoda-
mine-labeled internal standard (GeneScan-500 ROX; Ap-
plied Biosystems) mixture (40:1). After denaturation at
95°C for 2 minutes and cooling, the samples were size-
separated and detected. The size and profile of the PCR
products were determined using GeneScan Analysis
software v. 3.7.1. (Applied Biosystems). GeneScan anal-
ysis results in a Gaussian distribution of multiple peaks,
representing many different PCR products in case of
reactive lymphoproliferations but gives a single peak in
case of monoclonal lymphoproliferation. Oligoclonality is
defined as multiple peaks in a polyclonal background.
Results
We consecutively investigated 300 samples (from 218
patients) that were submitted for routine diagnostics. In
all patients a clinical diagnosis of malignant lymphopro-
liferative disease was initially considered. All samples
were studied by multiplex PCR-based HD and GS anal-
ysis of Ig/TCR gene rearrangements, whereas SB analy-
sis could be performed on only 176 out of the 300 sam-
ples (Table 1). Some samples were analyzed for both Ig
and TCR clonality. Overall, 258 samples were analyzed
by PCR for T-cell clonality; of these samples, 150 were
analyzed by TCRB SB. PCR IGH gene rearrangement
analysis was performed in 87 samples, and SB analysis
was performed in 48 of these samples.
Because of our position as a reference center and our
extensive expertise on TCR gene rearrangement analy-
sis, the focus of our study lies on T-cell clonality analysis.
SB and PCR analyses were, in principle, performed once.
In practice this means that Ig clonality was evaluated with
the IGHJ6 probe and in three different FR IGH multiplex
PCR reactions. In limited cases, additional SB and PCR
analysis of the IGK gene was performed. TCR clonality
was analyzed with two TCRB SB probes as well as with
TCRB and TCRG multiplex PCR protocols. Few samples
were studied by SB analysis for TCRG/TCRD gene rear-
rangements or for EBV genome and PCR analysis of
TCRD gene rearrangements. In case of doubtful or dis-
crepant results, assays were repeated.
High Level of Concordance between SB and
PCR Ig/TCR Gene Rearrangement Studies
Of 300 samples, 176 were analyzed simultaneously by
multiplex PCR and SB analysis (Table 1). Molecular data
were concordant for TCR analysis in 127 of 150 samples
(85%), whereas Ig gene rearrangement analysis was
Table 1. Summary of Performed SB- and PCR-Based Ig/TCR
Analysis
Clonality analysis
Samples (patients)
Multiplex PCR SB
TCR only 214 (155) 28 (24)
Ig only 39 (30) 3 (3)
Ig and TCR 47 (33) 145 (119)
Total 300 (218) 176 (146)
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concordant in 41 of 48 samples (85%). Table 2 shows the
proportion of concordant SB-PCR results in polyclonal
and clonal cases. The finding of a monoclonal T- or B-cell
population both by SB and PCR clonality analysis
strongly suggests a clonal (probably malignant) lympho-
proliferation. Polyclonal gene rearrangements in both as-
says are indicative of a reactive (benign) lymphoprolif-
eration. Nevertheless, it should be emphasized that the
results of molecular clonality studies should always be
interpreted in the context of clinical, histological, and
immunophenotypical data. In 30 samples derived from
27 patients, discordances were found between multiplex
PCR and SB analysis. In all of these samples, mono-
clonality was demonstrated by PCR analysis, whereas
SB did not show evidence for clonal Ig/TCR gene
rearrangements.
Evaluation of TCR Clonality as Demonstrated by
PCR Analysis with Nonclonal Results Observed
by SB Analysis
In 23 samples derived from 21 patients, multiplex PCR
analysis demonstrated clonal TCRB/TCRG gene rear-
rangements, which were not detected by SB analysis. In
17 samples, the molecular findings correlated with the
histopathological diagnosis of malignant T-cell prolifera-
tions (74%). (For an example of histologically proven
ALCL, see Figure 1.) In the remaining samples there was
Table 2. Concordance between SB- and PCR-Based Ig/TCR
Analysis in Polyclonal and Clonal Cases
SB-PCR concordance
Gene rearrangement target
Ig TCR
Total concordance 41/48 (85%) 127/150 (85%)
Polyclonal cases 25/41 (61%) 83/127 (65%)
Clonal cases 16/41 (39%) 44/127 (35%)
Figure 1. Skin localization of ALCL in case 4. A: Histology of ulcerating skin tumor. Skin biopsy specimen demonstrates localization of dermal infiltrate of large
cells with irregular nuclei (HE; magnification, 100). Note the large hallmark cells (inset) (HE; magnification, 600). B: The large neoplastic cells are strongly
positive for CD30 (magnification, 200). Note the strongly stained membrane and the dot-like staining in the Golgi complex area (inset) (magnification, 600).
C: The neoplastic cells also stain for CD4 (magnification, 200). D: PCR-based GeneScan analysis. Bi-allelic monoclonal TCRG gene rearrangements could be
identified in skin DNA.
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no clear indication for a T-cell malignancy at the time of
diagnosis (Table 3).
PCR analysis of the TCR locus identified clonal gene
rearrangements in six samples derived from five patients
in whom no diagnosis of T-cell leukemia or lymphoma
could be made. Case 11 was diagnosed as myeloprolif-
erative disease, unclassifiable. Case 14, diagnosed as
idiopathic hypereosinophilic syndrome (HES), showed
identical clonal TCR rearrangements in the BM and PB
samples by PCR analysis. Immunophenotyping of the PB
sample demonstrated a small T-cell population (0.3% of
leukocytes) with an aberrant phenotype (CD3/CD4/
CD5). It has been shown that in some HES patients,
abnormal monoclonal T cells can be found in PB.18–21
However, in the literature so far, no clonal T-cell popula-
tions identical to the one in PB have been detected in BM.
Further research should reveal the meaning of the clonal
T-cell population in BM. Because patients diagnosed with
idiopathic HES and associated clonal T-cell populations
are at risk of developing T-cell lymphoma,19,22,23 careful
follow-up is required in this case. Case 18 was admitted
to our hospital in 1994 and was diagnosed with CD30
cutaneous T-cell lymphoma. Although the patient was
clinically healthy without any signs of relapse, the PB
sample demonstrated monoclonal TCRB rearrangements
in 2004. The PCR analysis on the paraffin-embedded skin
tissue sample from 1994 demonstrated weak clonal
TCRB rearrangements, identical to the ones found in the
PB sample 10 years after presentation. We strongly rec-
ommend follow-up of this patient as well. A skin relapse of
an ALCL was diagnosed in case 20. Staging resulted in
the detection of weak clonal TCRB gene rearrangements
in the BM sample, not identical to the ones found in the
skin. Flow cytometry and histopathology did not demon-
strate localization of malignant lymphoma. Finally, case
21 was diagnosed as reactive lymphadenopathy after
extensive immunohistochemical and flow cytometric
analysis of the LN sample.
Evaluation of Ig Clonality as Demonstrated by
PCR Analysis with Nonclonal Results Observed
by SB Analysis
In seven samples derived from six patients, multiplex
PCR analysis demonstrated clonal B-cell populations that
were not detected by SB analysis (Table 4). IGH mono-
clonality was detected in the LN sample of case 27, who
suffered from human immunodeficiency virus and EBV
infection. The histopathological diagnosis of B-post-
transplantation lymphoproliferative disorder-associated
disease was made from the LN sample (Figure 2). This
polymorphic B-cell lymphoproliferative disorder also oc-
curs in immunodeficient states outside the posttransplant
setting and comprises 5% of human immunodeficiency
virus-associated lymphomas. Most cases have clonally
rearranged IGH and IGK genes with the TCRB gene in the
germline configuration as found by SB analysis.24 In ad-
dition, TCR oligoclonality was detected in the sample by
PCR analysis (Figure 2). Although SB analysis of the IGH
locus did not provide evidence for malignancy, the pres-
ence of a clonal EBV genome in the LN sample was
Table 3. Discordances between SB and PCR Results in Suspect T-Cell Proliferations
Case no. Sample no.
Final clinicohistological
diagnosis*
SB PCR procedure
TCRB TCRG TCRD TCRB TCRG TCRD
1 2001-146 (skin) LyP G ND ND C C ND
2 2001-148 (LN) AILT G ND ND C C ND
3 2001-152 (PB) T-LGL G G ND C C ND
4 2001-162 (skin) ALCL G G ND C C ND
5 2002-003 (LN) Peripheral T-NHL, NOS G ND ND C P P
6 2002-022 (PB) MF G ND ND C C ND
7 2002-033 (LN) CD30 CTCL G ND ND C C ND
8 2002-047 (PB) T-LGL G ND ND C C ND
9 2002-050 (LN) ALCL G ND G C P C
10 2002-113 (BM) T-ALL G ND G C P C
11 2002-144 (BM) MPD-U G G G C C P
12 2003-022 (LN) AILT G G G C C ND
13 2003-172 (BM) T-LBL G G G C C C
14 2003-236 (BM) HES G ND ND C P ND
2003-296 (PB) HES G ND ND C C ND
15 2003-245 (skin) MF G G G C P ND
16 2003-270 (PB) SS G ND ND C P ND
2004-007 (LN) SS G ND ND C P ND
17 2004-001 (skin) SS G ND ND C P ND
18† 2004-004 (PB) Reactive G ND ND C C ND
19 2004-005 (skin) CD30 CTCL G ND ND C P ND
20 2004-011 (BM) Reactive G ND ND C P ND
21 2004-020 (LN) Reactive G ND ND C C ND
R, rearranged; G, germline; C, clonal; P, polyclonal; ND, not done.
*AILT, angioimmunoblastic T-cell lymphoma; ALCL, anaplastic large-cell lymphoma; CTCL, cutaneous T-cell lymphoma; HES, hypereosinophilic
syndrome; LyP, lymphomatoid papulosis; MF, mycosis fungoides; MPD-U, myeloproliferative disease, unclassifiable; PTLD, post-transplant
lymphoproliferative disorder; SS, Se´zary syndrome; T-ALL, T-cell acute lymphoblastic leukemia; T-LBL, T-cell lymphoblastic lymphoma; T-LGL, T-cell
large granular lymphocyte leukemia; T-NHL NOS, T-cell non-Hodgkin’s lymphoma, not otherwise specified.
†Case 18 was diagnosed with a CD30 CTCL 10 years before.
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identified by SB analysis (data not shown). In four of the
other six samples, the IGH PCR results agreed with bi-
opsy histology and immunophenotypical analysis. All to-
gether, five of seven (71%) B-cell proliferations showed
concordant PCR and histology results.
The two remaining samples were diagnosed as reac-
tive lesions after extensive histopathological evaluation.
In the skin sample of case 22, a weak monoclonal gene
rearrangement was detected by PCR analysis. On his-
topathological examination, the lymphocytic infiltrate al-
most exclusively contained T cells. This case was dis-
cussed in the Dutch Cutaneous Lymphoma Working
Group, and a diagnosis of dermatitis was made. The
small amount of polyclonal B cells in the cutaneous infil-
trate might explain the finding of (oligo)clonal IGH gene
rearrangements.25,26 Although a weak clonal IGH gene
rearrangement was detected in the BM sample of case
24 by PCR analysis, immunophenotyping only detected a
reactive plasma cell population, and no abnormal B cells
were seen by cytomorphological evaluation.
Discussion
We evaluated a group of 218 patients with an initial
suspicion of lymphoproliferative disorders to estimate
whether the newly designed primers and PCR protocols
of the BIOMED-2 Concerted Action method could reliably
replace SB analysis in a routine diagnostic setting. A total
of 300 DNA samples was analyzed by two PCR-based
strategies (HD and GS analysis), whereas a series of 176
DNA samples were analyzed by both SB and PCR anal-
yses. The fact that SB analysis could not be performed in
124 samples further stresses the need for reliable PCR
assays. When the SB and PCR approaches were com-
pared and related to the final diagnosis, PCR and SB
results of both T- and B-cell clonality analyses were con-
cordant in 85% of samples.
In those samples in which the SB-PCR results were
discordant, the PCR results appeared to correlate with
the histopathological diagnosis in 22 of 30 cases (73%).
Although PCR analyses showed unconfirmed clonal re-
sults in 27% of cases in comparison with the SB analysis,
the number of false-negative SB results in cases of true
malignancy was unexpectedly high. Further research
and follow-up should estimate the meaning of small
clonal T- or B-cell populations in nonmalignant cases as
determined by PCR-based techniques. Most recently, the
BIOMED-2-based primers and protocols were studied in
a series of 100 well-defined samples of reactive lym-
phoproliferations, and (oligo)clonality was detected in
10% of cases (A.W. Langerak, unpublished data).
Based on our research and published reports, we
strongly recommend careful follow-up of nonmalignant
cases with clonal lymphoproliferations, because Ig/TCR
clonality might be an early sign of an underlying hema-
tological malignancy. Frequent clinical and histological
follow-up on PB, BM, or LN samples is required. This
might result in diagnosing patients in early stage disease,
thus favoring prognosis and survival. The detection of
identical T- or B-cell clones in a tissue sample and in PB
is of great importance in staging lymphoid malignancies
and is of prognostic relevance.27–30 It should, however,
be noted that the finding of (oligo)clonality might not
always be clinically significant. (Oligo)clonal T-cell pop-
ulations can be detected in PB of the elderly,31,32 in
patients diagnosed with autoimmune diseases, and in
patients with viral infection.33 In cutaneous T-cell lym-
phoma, the detection of an identical monoclonal TCR
gene rearrangement in skin and extracutaneous tissues
has been proven to be an independent prognostic mark-
er.34,35 In addition, detection of the same clonal gene
rearrangements in multiple skin biopsy specimens at the
time of diagnosis may provide prognostic information
related to disease progression.36 Therefore, if possible,
we recommend studying multiple (parallel) samples from
multiple suspect localizations at initial disease presenta-
tion. In addition, follow-up samples should be evaluated
when disease progression is suspected.
The detection of a clonal B- or T-cell population can
facilitate diagnosis in patients in whom clinical, his-
topathological, and immunophenotypical findings are
consistent but not entirely typical of a malignant lympho-
proliferation. The importance of accurate molecular
clonality diagnostics is supported by the fact that the
current diagnostic criteria for patients with SS and T-LGL
leukemia include the presence of a clonal TCR gene
rearrangement in PB.37,38
The BIOMED-2 multiplex PCR approach is a rapid and
reliable procedure that is far more sensitive than SB
analysis in detecting clonality in suspect lymphoprolifera-
Table 4. Discordances between SB and PCR Results in Suspect B-Cell Proliferations
Case no. Sample no.
Final clinico-
histological diagnosis*
SB PCR procedure
IGH IGK EBV FR1 FR2 FR3 IGK
22 2001-125 (skin) Dermatitis G ND ND C C C ND
23 2001-170 (PB) MM G ND ND C C C ND
24 2002-011 (BM) Reactive G ND ND C C P ND
25 2002-096A (LN) DLBCL G ND ND C C C ND
2002-096B (BM) DLBCL G ND ND C C C ND
26 2002-122 (skin) DLBCL G G ND C C P C
27† 2003-242 (LN) B-PTLD G G R C C C ND
G, germline; R, rearranged; C, clonal; P, polyclonal; ND, not done.
*DLBCL, diffuse large B-cell lymphoma; MM, multiple myeloma.
†Case no. 27 was diagnosed with a PTLD-associated disease (HIV and EBV positive) and demonstrated oligoclonal TCR rearrangements in the LN
sample by PCR analysis (Figure 2).
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tions. The final clinico-histopathological diagnosis corre-
lates well with PCR results in a higher number of patients
in comparison with SB results. Therefore, it seems that
the “gold standard” of SB analysis can now be reliably
replaced in a routine laboratory setting. Essentially, this
not only holds true for Ig clonality analysis but also for
Figure 2. Polymorphic B-cell PTLD-associated disease in case 27. A: Histology of LN. There was no recognizable lymph node architecture (HE; magnification, 200).
There were numerous blasts (inset) (HE; magnification,600) intermingled with an infiltrate of smaller lymphocytes. B: EBER-ISH showed scattered positively stained
nuclei, indicating the presence of EBV RNA (magnification, 400). C: CD3 staining of the predominantly small T cells. Occasionally, larger cells stained positively
(magnification,400).D: CD20 stained themajority of the large blasts. Note the numerousmitotic figures (arrows) (magnification,400). E and F: PCR-basedGeneScan
analysis of LN DNA. Oligoclonal TCRB gene rearrangements could be identified (E), whereas a monoclonal IGH gene rearrangement was detected (F).
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TCR clonality assessment, as demonstrated in this study.
There was no difference in clonality detection rate be-
tween TCRB and TCRG gene rearrangement analysis,
whereas the combined analysis clearly showed addi-
tional value. We detected the highest number of clonal
IGH gene rearrangements when using multiplex combi-
nation A and B (FR1  FR2 primers) (Table 5), but the
combined information from all three FR PCR reactions
resulted in a higher number of clonal cases. Although SB
IGH gene rearrangement analysis remains a reliable and
helpful additional test, the PCR approach is strongly pre-
ferred. The finding of polyclonal IGH gene rearrange-
ments by PCR analysis in case of strong suspicion of a
B-cell malignancy would indicate performing additional
PCR-based IGK analysis. In two cases of our series,
analysis of the IGK locus was of additional value. We
detected clonal IGK gene rearrangements in a case of
follicular lymphoma and a case of cutaneous B-cell lym-
phoma, whereas polyclonal gene rearrangements were
found on IGH analysis. In case of T-cell clonality diagnos-
tics, our TCRB/TCRG protocols are superior to SB anal-
ysis of the TCRB locus. The latter, however, may still be a
valuable test under certain conditions.
In conclusion, both HD and GS are reliable techniques
with completely concordant results. Because of its en-
hanced speed, accuracy, and interpretation, GS analysis
is slightly favored over HD analysis. Based on our current
results and extensive experience with TCR gene studies
in general, we now propose a flowchart that demon-
strates the most efficient and sensitive strategy in detect-
ing T-cell clonality (Figure 3). This strategy holds true for
fresh or frozen tissue samples and may be applicable to
paraffin-embedded tissue samples, provided that DNA
quality is such that PCR products of 300 bp can be
amplified.
Acknowledgments
We are grateful to Prof. Dr. R. Benner (Department of
Immunology, Erasmus MC) for continuous support,
Monique Oud and Jos de Vos for technical assistance,
and Tar van Os for help in preparing the figures.
References
1. Van Dongen JJ, Wolvers-Tettero IL: Analysis of immunoglobulin and T
cell receptor genes. Part I: basic and technical aspects. Clin Chim
Acta 1991, 198:1–91
2. Derksen PW, Langerak AW, Kerkhof E, Wolvers-Tettero IL, Boor PP,
Mulder AH, Vrints LW, Coebergh JW, van Krieken JH, Schuuring E,
Kluin PM, van Dongen JJ: Comparison of different polymerase chain
reaction-based approaches for clonality assessment of immunoglob-
ulin heavy-chain gene rearrangements in B-cell neoplasia. Mod
Pathol 1999, 12:794–805
3. Arber DA, Braziel RM, Bagg A, Bijwaard KE: Evaluation of T cell
receptor testing in lymphoid neoplasms: results of a multicenter study
of 29 extracted DNA and paraffin-embedded samples. J Mol Diagn
2001, 3:133–140
4. Shadrach B, Warshawsky I: A comparison of multiplex and monoplex
T-cell receptor gamma PCR. Diagn Mol Pathol 2004, 13:127–134
5. Droese J, Langerak AW, Groenen PJ, Bruggemann M, Neumann P,
Wolvers-Tettero IL, Van Altena MC, Kneba M, Van Dongen JJ: Vali-
dation of BIOMED-2 multiplex PCR tubes for detection of TCRB
gene rearrangements in T-cell malignancies. Leukemia 2004,
18:1531–1538
6. Beishuizen A, Verhoeven MA, Mol EJ, Breit TM, Wolvers-Tettero IL,
van Dongen JJ: Detection of immunoglobulin heavy-chain gene rear-
rangements by Southern blot analysis: recommendations for optimal
results. Leukemia 1993, 7:2045–2053
7. Langerak AW, Wolvers-Tettero IL, van Dongen JJ: Detection of T cell
receptor beta (TCRB) gene rearrangement patterns in T cell malig-
nancies by Southern blot analysis. Leukemia 1999, 13:965–974
8. van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel
Figure 3. Strategy for BIOMED-2 multiplex PCR TCR clonality analysis in
suspect T-cell proliferations. In TCR or TCR-negative T-cell prolifera-
tions, there is no clear evidence-based preference for either the TCRB or
TCRG locus as the initial target for clonality diagnostics. Thus, either TCRB or
TCRG can be used as the first line target, followed by the other locus as the
second target. For TCR T-cell proliferations, the TCRG locus is the clear
first line target for clonality assessment, followed by TCRD as the second
target. In the absence of clonal TCR gene rearrangements in PCR, SB analysis
might still be considered for all suspect T-cell proliferations, provided that
enough high-quality DNA is available. Although the PCR strategy as de-
scribed here is suitable for fresh or frozen tissue samples, it could possibly be
applied to DNA isolated from paraffin-embedded tissue samples, provided
that DNA quality is such that PCR products of 300 bp can be amplified.
Table 5. Clonality Detection Rate of Different Targets in PCR-Based Ig/TCR Clonality Assessment
IGH TCR
FR1 FR2 FR3 FR123 TCRB TCRG TCRB  TCRG
Clonality (%) 94 88 55 100 87 86 100
Per target (31/33) (29/33) (18/33) (33/33) (103/119) (102/119) (119/119)
502 Sandberg et al
JMD October 2005, Vol. 7, No. 4
M, Lavender FL, Delabesse E, Davi F, Schuuring E, Garcia-Sanz R,
van Krieken JH, Droese J, Gonzalez D, Bastard C, White HE, Spaar-
garen M, Gonzalez M, Parreira A, Smith JL, Morgan GJ, Kneba M,
Macintyre EA: Design and standardization of PCR primers and pro-
tocols for detection of clonal immunoglobulin and T-cell receptor
gene recombinations in suspect lymphoproliferations: report of the
BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003,
17:2257–2317
9. Sandberg Y, Heule F, Lam K, Lugtenburg PJ, Wolvers-Tettero IL, van
Dongen JJ, Langerak AW: Molecular immunoglobulin/T-cell receptor
clonality analysis in cutaneous lymphoproliferations: experience with
the BIOMED-2 standardized polymerase chain reaction protocol.
Haematologica 2003, 88:659–670
10. Jaffe ES HN, Stein H, Vardiman JW: World Health Organization Clas-
sification of Tumours. Pathology and Genetics of Tumours of Haema-
topoietic and Lymphoid Tissues. Lyon, IARC Press, 2001
11. Moreau EJ, Langerak AW, van Gastel-Mol EJ, Wolvers-Tettero IL,
Zhan M, Zhou Q, Koop BF, van Dongen JJ: Easy detection of all T cell
receptor gamma (TCRG) gene rearrangements by Southern blot
analysis: recommendations for optimal results. Leukemia 1999,
13:1620–1626
12. Breit TM, Wolvers-Tettero IL, Beishuizen A, Verhoeven MA, van Wer-
ing ER, van Dongen JJ: Southern blot patterns, frequencies, and
junctional diversity of T-cell receptor-delta gene rearrangements in
acute lymphoblastic leukemia. Blood 1993, 82:3063–3074
13. Raab-Traub N, Flynn K: The structure of the termini of the Epstein-
Barr virus as a marker of clonal cellular proliferation. Cell 1986,
47:883–889
14. Drexler H: The Leukemia-Lymphoma Cell Line Facts Book. San Di-
ego, CA, Academic Press, 2001
15. Langerak AW, Wolvers-Tettero LM, van Dongen JJM: Immunoglobu-
lin and T-cell receptor gene analysis in the diagnosis of lymphoid
malignancies. Rev Clin Exp Hematol 1997, 3:3–27
16. Linke B, Bolz I, Fayyazi A, von Hofen M, Pott C, Bertram J, Hidde-
mann W, Kneba M: Automated high resolution PCR fragment analysis
for identification of clonally rearranged immunoglobulin heavy chain
genes. Leukemia 1997, 11:1055–1062
17. Kneba M, Bolz I, Linke B, Hiddemann W: Analysis of rearranged
T-cell receptor beta-chain genes by polymerase chain reaction (PCR)
DNA sequencing and automated high resolution PCR fragment anal-
ysis. Blood 1995, 86:3930–3937
18. Kitano K, Ichikawa N, Shimodaira S, Ito T, Ishida F, Kiyosawa K:
Eosinophilia associated with clonal T-cell proliferation. Leuk Lym-
phoma 1997, 27:335–342
19. Simon HU, Plotz SG, Dummer R, Blaser K: Abnormal clones of T cells
producing interleukin-5 in idiopathic eosinophilia. N Engl J Med 1999,
341:1112–1120
20. Brugnoni D, Airo P, Rossi G, Bettinardi A, Simon HU, Garza L, Tosoni
C, Cattaneo R, Blaser K, Tucci A: A case of hypereosinophilic syn-
drome is associated with the expansion of a CD3CD4 T-cell
population able to secrete large amounts of interleukin-5. Blood 1996,
87:1416–1422
21. Cogan E, Schandene L, Crusiaux A, Cochaux P, Velu T, Goldman M:
Brief report: clonal proliferation of type 2 helper T cells in a man with
the hypereosinophilic syndrome. N Engl J Med 1994, 330:535–538
22. Roufosse F, Schandene L, Sibille C, Willard-Gallo K, Kennes B, Efira
A, Goldman M, Cogan E: Clonal Th2 lymphocytes in patients with the
idiopathic hypereosinophilic syndrome. Br J Haematol 2000,
109:540–548
23. O’Shea JJ, Jaffe ES, Lane HC, MacDermott RP, Fauci AS: Peripheral
T cell lymphoma presenting as hypereosinophilia with vasculitis: clin-
ical, pathologic, and immunologic features. Am J Med 1987,
82:539–545
24. Nador RG, Chadburn A, Gundappa G, Cesarman E, Said JW,
Knowles DM: Human immunodeficiency virus (HIV)-associated poly-
morphic lymphoproliferative disorders. Am J Surg Pathol 2003,
27:293–302
25. Nihal M, Mikkola D, Wood GS: Detection of clonally restricted immu-
noglobulin heavy chain gene rearrangements in normal and lesional
skin: analysis of the B cell component of the skin-associated lym-
phoid tissue and implications for the molecular diagnosis of cutane-
ous B cell lymphomas. J Mol Diagn 2000, 2:5–10
26. Elenitoba-Johnson KS, Bohling SD, Mitchell RS, Brown MS, Robeto-
rye RS: PCR analysis of the immunoglobulin heavy chain gene in
polyclonal processes can yield pseudoclonal bands as an artifact of
low B cell number. J Mol Diagn 2000, 2:92–96
27. Muche JM, Sterry W, Gellrich S, Rzany B, Audring H, Lukowsky A:
Peripheral blood T-cell clonality in mycosis fungoides and nonlym-
phoma controls. Diagn Mol Pathol 2003, 12:142–150
28. Mitterbauer-Hohendanner G, Mannhalter C, Winkler K, Mitterbauer M,
Skrabs C, Chott A, Simonitsch-Klupp I, Gleiss A, Lechner K, Jaeger
U: Prognostic significance of molecular staging by PCR-amplification
of immunoglobulin gene rearrangements in diffuse large B-cell lym-
phoma (DLBCL). Leukemia 2004, 18:1102–1107
29. Scarisbrick JJ, Whittaker S, Evans AV, Fraser-Andrews EA, Child FJ,
Dean A, Russell-Jones R: Prognostic significance of tumor burden in
the blood of patients with erythrodermic primary cutaneous T-cell
lymphoma. Blood 2001, 97:624–630
30. Theodorou I, Bigorgne C, Delfau MH, Lahet C, Cochet G, Vidaud M,
Raphael M, Gaulard P, Farcet JP: VJ rearrangements of the TCR
gamma locus in peripheral T-cell lymphomas: analysis by polymer-
ase chain reaction and denaturing gradient gel electrophoresis.
J Pathol 1996, 178:303–310
31. Posnett DN, Sinha R, Kabak S, Russo C: Clonal populations of T cells
in normal elderly humans: the T cell equivalent to “benign monoclonal
gammapathy.” J Exp Med 1994, 179:609–618
32. Delfau-Larue MH, Laroche L, Wechsler J, Lepage E, Lahet C, Asso-
Bonnet M, Bagot M, Farcet JP: Diagnostic value of dominant T-cell
clones in peripheral blood in 363 patients presenting consecutively
with a clinical suspicion of cutaneous lymphoma. Blood 2000,
96:2987–2992
33. Hodges E, Krishna MT, Pickard C, Smith JL: Diagnostic role of tests
for T cell receptor (TCR) genes. J Clin Pathol 2003, 56:1–11
34. Assaf C, Hummel M, Steinhoff M, Geilen CC, Orawa H, Stein H,
Orfanos CE: Early TCR-{beta} and TCR-{gamma} PCR detection of
T-cell clonality indicates minimal tumor disease in lymph nodes of
cutaneous T-cell lymphoma: diagnostic and prognostic implications.
Blood 2005, 105:503–510
35. Fraser-Andrews EA, Woolford AJ, Russell-Jones R, Seed PT, Whit-
taker SJ: Detection of a peripheral blood T cell clone is an indepen-
dent prognostic marker in mycosis fungoides. J Invest Dermatol
2000, 114:117–121
36. Vega F, Luthra R, Medeiros LJ, Dunmire V, Lee SJ, Duvic M, Jones D:
Clonal heterogeneity in mycosis fungoides and its relationship to
clinical course. Blood 2002, 100:3369–3373
37. Loughran TP Jr, Starkebaum G, Aprile JA: Rearrangement and ex-
pression of T-cell receptor genes in large granular lymphocyte leu-
kemia. Blood 1988, 71:822–824
38. Vonderheid EC, Bernengo MG, Burg G, Duvic M, Heald P, Laroche L,
Olsen E, Pittelkow M, Russell-Jones R, Takigawa M, Willemze R:
Update on erythrodermic cutaneous T-cell lymphoma: report of the
International Society for Cutaneous Lymphomas. J Am Acad Derma-
tol 2002, 46:95–106
Ig/TCR Multiplex PCR in Routine Diagnostics 503
JMD October 2005, Vol. 7, No. 4
